-
1
-
-
84861325987
-
Improving care for patients with type 2 diabetes: Applying management guidelines and algorithms, and a review of new evidence for incretin agents and lifestyle intervention
-
Blonde L (2011) Improving care for patients with type 2 diabetes: Applying management guidelines and algorithms, and a review of new evidence for incretin agents and lifestyle intervention. Am J Manag Care 17(Suppl 14):S368-S376.
-
(2011)
Am J Manag Care
, vol.17
, pp. S368-S376
-
-
Blonde, L.1
-
2
-
-
79960972545
-
Emerging therapeutic approaches for the management of diabetes mellitus and macrovascular complications
-
Golden SH (2011) Emerging therapeutic approaches for the management of diabetes mellitus and macrovascular complications. Am J Cardiol 108(3, Suppl):59B-67B.
-
(2011)
Am J Cardiol
, vol.108
, Issue.3
, pp. 59B-67B
-
-
Golden, S.H.1
-
3
-
-
84975856269
-
Economic costs of diabetes in the U.S. in 2012
-
American Diabetes Association (2013) Economic costs of diabetes in the U.S. in 2012. Diabetes Care 36(4):1033-1046.
-
(2013)
Diabetes Care
, vol.36
, Issue.4
, pp. 1033-1046
-
-
-
4
-
-
84883175908
-
Skin blood flow response to locally applied mechanical and thermal stresses in the diabetic foot
-
Jan YK, Shen S, Foreman RD, Ennis WJ (2013) Skin blood flow response to locally applied mechanical and thermal stresses in the diabetic foot. Microvasc Res 89:40-46.
-
(2013)
Microvasc Res
, vol.89
, pp. 40-46
-
-
Jan, Y.K.1
Shen, S.2
Foreman, R.D.3
Ennis, W.J.4
-
5
-
-
34248225758
-
Cellular and molecular basis of wound healing in diabetes
-
Brem H, Tomic-Canic M (2007) Cellular and molecular basis of wound healing in diabetes. J Clin Invest 117(5):1219-1222.
-
(2007)
J Clin Invest
, vol.117
, Issue.5
, pp. 1219-1222
-
-
Brem, H.1
Tomic-Canic, M.2
-
6
-
-
3042660408
-
Protocol for the successful treatment of pressure ulcers
-
Suppl
-
Brem H, Lyder C (2004) Protocol for the successful treatment of pressure ulcers. Am J Surg 188(1A Suppl):9-17.
-
(2004)
Am J Surg
, vol.188
, Issue.1
, pp. 9-17
-
-
Brem, H.1
Lyder, C.2
-
7
-
-
33744780764
-
The molecular biology of chronic wounds and delayed healing in diabetes
-
Blakytny R, Jude E (2006) The molecular biology of chronic wounds and delayed healing in diabetes. Diabet Med 23(6):594-608.
-
(2006)
Diabet Med
, vol.23
, Issue.6
, pp. 594-608
-
-
Blakytny, R.1
Jude, E.2
-
8
-
-
84891762764
-
Inpatient management of diabetic foot disorders: A clinical guide
-
Wukich DK, et al. (2013) Inpatient management of diabetic foot disorders: a clinical guide. Diabetes Care 36(9):2862-2871.
-
(2013)
Diabetes Care
, vol.36
, Issue.9
, pp. 2862-2871
-
-
Wukich, D.K.1
-
9
-
-
84885930487
-
The system of care for the diabetic foot: Objectives, outcomes, and opportunities
-
Barshes NR, et al. (2013) The system of care for the diabetic foot: objectives, outcomes, and opportunities. Diabet Foot Ankle, 10.3402/dfa.v4i0.21847.
-
(2013)
Diabet Foot Ankle
-
-
Barshes, N.R.1
-
10
-
-
39449127714
-
Estimating the prevalence of limb loss in the United States: 2005 to 2050
-
Ziegler-Graham K, MacKenzie EJ, Ephraim PL, Travison TG, Brookmeyer R (2008) Estimating the prevalence of limb loss in the United States: 2005 to 2050. Arch Phys Med Rehabil 89(3):422-429.
-
(2008)
Arch Phys Med Rehabil
, vol.89
, Issue.3
, pp. 422-429
-
-
Ziegler-Graham, K.1
MacKenzie, E.J.2
Ephraim, P.L.3
Travison, T.G.4
Brookmeyer, R.5
-
11
-
-
84875894414
-
Influence of osteomyelitis location in the foot of diabetic patients with transtibial amputation
-
Faglia E, Clerici G, Caminiti M, Curci V, Somalvico F (2013) Influence of osteomyelitis location in the foot of diabetic patients with transtibial amputation. Foot Ankle Int 34(2):222-227.
-
(2013)
Foot Ankle Int
, vol.34
, Issue.2
, pp. 222-227
-
-
Faglia, E.1
Clerici, G.2
Caminiti, M.3
Curci, V.4
Somalvico, F.5
-
12
-
-
0037180517
-
Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures
-
Tepper OM, et al. (2002) Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106(22):2781-2786.
-
(2002)
Circulation
, vol.106
, Issue.22
, pp. 2781-2786
-
-
Tepper, O.M.1
-
13
-
-
33847069274
-
Diabetes impairs endothelial progenitor cell-mediated blood vessel formation in response to hypoxia
-
Capla JM, et al. (2007) Diabetes impairs endothelial progenitor cell-mediated blood vessel formation in response to hypoxia. Plast Reconstr Surg 119(1):59-70.
-
(2007)
Plast Reconstr Surg
, vol.119
, Issue.1
, pp. 59-70
-
-
Capla, J.M.1
-
14
-
-
4043184065
-
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1
-
Ceradini DJ, et al. (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10(8):858-864.
-
(2004)
Nat Med
, vol.10
, Issue.8
, pp. 858-864
-
-
Ceradini, D.J.1
-
15
-
-
73249140173
-
Adenoviral transfer of HIF-1alpha enhances vascular responses to critical limb ischemia in diabetic mice
-
Sarkar K, Fox-Talbot K, Steenbergen C, Bosch-Marcé M, Semenza GL (2009) Adenoviral transfer of HIF-1alpha enhances vascular responses to critical limb ischemia in diabetic mice. Proc Natl Acad Sci USA 106(44):18769-18774.
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, Issue.44
, pp. 18769-18774
-
-
Sarkar, K.1
Fox-Talbot, K.2
Steenbergen, C.3
Bosch-Marcé, M.4
Semenza, G.L.5
-
16
-
-
84861644790
-
Systemic VHL gene functions and the VHL disease
-
Bader HL, Hsu T (2012) Systemic VHL gene functions and the VHL disease. FEBS Lett 586(11):1562-1569.
-
(2012)
FEBS Lett
, vol.586
, Issue.11
, pp. 1562-1569
-
-
Bader, H.L.1
Hsu, T.2
-
17
-
-
74549161719
-
HIF-1alpha dysfunction in diabetes
-
Thangarajah H, et al. (2010) HIF-1alpha dysfunction in diabetes. Cell Cycle 9(1):75-79.
-
(2010)
Cell Cycle
, vol.9
, Issue.1
, pp. 75-79
-
-
Thangarajah, H.1
-
18
-
-
69449108536
-
The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues
-
Thangarajah H, et al. (2009) The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues. Proc Natl Acad Sci USA 106(32):13505-13510.
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, Issue.32
, pp. 13505-13510
-
-
Thangarajah, H.1
-
19
-
-
0033599057
-
Disorders of iron metabolism
-
Andrews NC (1999) Disorders of iron metabolism. N Engl J Med 341(26):1986-1995.
-
(1999)
N Engl J Med
, vol.341
, Issue.26
, pp. 1986-1995
-
-
Andrews, N.C.1
-
21
-
-
0037431377
-
Methoxylation of desazadesferrithiocin analogues: Enhanced iron clearing efficiency
-
Bergeron RJ, et al. (2003) Methoxylation of desazadesferrithiocin analogues: Enhanced iron clearing efficiency. J Med Chem 46(8):1470-1477.
-
(2003)
J Med Chem
, vol.46
, Issue.8
, pp. 1470-1477
-
-
Bergeron, R.J.1
-
22
-
-
58049209727
-
Stabilization of HIF-1alpha is critical to improve wound healing in diabetic mice
-
Botusan IR, et al. (2008) Stabilization of HIF-1alpha is critical to improve wound healing in diabetic mice. Proc Natl Acad Sci USA 105(49):19426-19431.
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, Issue.49
, pp. 19426-19431
-
-
Botusan, I.R.1
-
23
-
-
0034108348
-
The role of allopurinol and deferoxamine in preventing pressure ulcers in pigs
-
Sundin BM, et al. (2000) The role of allopurinol and deferoxamine in preventing pressure ulcers in pigs. Plast Reconstr Surg 105(4):1408-1421.
-
(2000)
Plast Reconstr Surg
, vol.105
, Issue.4
, pp. 1408-1421
-
-
Sundin, B.M.1
-
24
-
-
0033848069
-
The effects of conjugated deferoxamine in porcine skin flaps
-
Hom DB, Goding GS, Jr, Price JA, Pernell KJ, Maisel RH (2000) The effects of conjugated deferoxamine in porcine skin flaps. Head Neck 22(6):579-584.
-
(2000)
Head Neck
, vol.22
, Issue.6
, pp. 579-584
-
-
Hom, D.B.1
Goding, G.S.2
Price, J.A.3
Pernell, K.J.4
Maisel, R.H.5
-
25
-
-
33845185380
-
Syntheses and therapeutic potential of hydroxamic acid based siderophores and analogs
-
Miller MJ (1989) Syntheses and therapeutic potential of hydroxamic acid based siderophores and analogs. Chem Rev 89(7):1563-1579.
-
(1989)
Chem Rev
, vol.89
, Issue.7
, pp. 1563-1579
-
-
Miller, M.J.1
-
26
-
-
84856813200
-
Status of surfactants as penetration enhancers in transdermal drug delivery
-
Som I, Bhatia K, Yasir M (2012) Status of surfactants as penetration enhancers in transdermal drug delivery. J Pharm Bioallied Sci 4(1):2-9.
-
(2012)
J Pharm Bioallied Sci
, vol.4
, Issue.1
, pp. 2-9
-
-
Som, I.1
Bhatia, K.2
Yasir, M.3
-
27
-
-
0036331403
-
Polymers in transdermal drug delivery systems
-
Kandavilli S, Nair V, Panchagnula R (2002) Polymers in transdermal drug delivery systems. Pharm Tech 26(5):62-81.
-
(2002)
Pharm Tech
, vol.26
, Issue.5
, pp. 62-81
-
-
Kandavilli, S.1
Nair, V.2
Panchagnula, R.3
-
28
-
-
3843081845
-
Physicochemical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical administration
-
Müller-Goymann CC (2004) Physicochemical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical administration. Eur J Pharm Biopharm 58(2):343-356.
-
(2004)
Eur J Pharm Biopharm
, vol.58
, Issue.2
, pp. 343-356
-
-
Müller-Goymann, C.C.1
-
29
-
-
57049179546
-
Reverse polymeric micelles for pharmaceutical applications
-
Jones M-C, Gao H, Leroux J-C (2008) Reverse polymeric micelles for pharmaceutical applications. J Control Release 132(3):208-215.
-
(2008)
J Control Release
, vol.132
, Issue.3
, pp. 208-215
-
-
Jones, M.-C.1
Gao, H.2
Leroux, J.-C.3
-
30
-
-
0028291096
-
Organogel-based system for transdermal delivery of propranolol
-
Bhatnagar S, Vyas SP (1994) Organogel-based system for transdermal delivery of propranolol. J Microencapsul 11(4):431-438.
-
(1994)
J Microencapsul
, vol.11
, Issue.4
, pp. 431-438
-
-
Bhatnagar, S.1
Vyas, S.P.2
-
31
-
-
0037278664
-
Development and in vitro evaluation of diltiazem hydrochloride transdermal patches based on povidone-ethylcellulose matrices
-
Gupta R, Mukherjee B (2003) Development and in vitro evaluation of diltiazem hydrochloride transdermal patches based on povidone-ethylcellulose matrices. Drug Dev Ind Pharm 29(1):1-7.
-
(2003)
Drug Dev Ind Pharm
, vol.29
, Issue.1
, pp. 1-7
-
-
Gupta, R.1
Mukherjee, B.2
-
32
-
-
0034630373
-
Effect of penetration enhancers on isosorbide dinitrate penetration through rat skin from a transdermal therapeutic system
-
Gabiga H, Cal K, Janicki S (2000) Effect of penetration enhancers on isosorbide dinitrate penetration through rat skin from a transdermal therapeutic system. Int J Pharm 199(1):1-6.
-
(2000)
Int J Pharm
, vol.199
, Issue.1
, pp. 1-6
-
-
Gabiga, H.1
Cal, K.2
Janicki, S.3
-
33
-
-
0000524855
-
Formulation and in vitro evaluation of polymeric films of diltiazem hydrochloride and indomethacin for transdermal administration
-
Rao PR, Diwan PV (1998) Formulation and in vitro evaluation of polymeric films of diltiazem hydrochloride and indomethacin for transdermal administration. Drug Dev Ind Pharm 24(4):327-336.
-
(1998)
Drug Dev Ind Pharm
, vol.24
, Issue.4
, pp. 327-336
-
-
Rao, P.R.1
Diwan, P.V.2
-
34
-
-
0016610679
-
Percutaneous absorption on the relevance of in vitro data
-
Franz TJ (1975) Percutaneous absorption on the relevance of in vitro data. J Invest Dermatol 64(3):190-195.
-
(1975)
J Invest Dermatol
, vol.64
, Issue.3
, pp. 190-195
-
-
Franz, T.J.1
-
35
-
-
0028810329
-
Fourier transform Raman spectroscopy of interactions between the penetration enhancer dimethyl sulfoxide and human stratum corneum
-
Anigbogu AN, Williams AC, Barry BW, Edwards HG (1995) Fourier transform Raman spectroscopy of interactions between the penetration enhancer dimethyl sulfoxide and human stratum corneum. Int J Pharm 125(2):265-282.
-
(1995)
Int J Pharm
, vol.125
, Issue.2
, pp. 265-282
-
-
Anigbogu, A.N.1
Williams, A.C.2
Barry, B.W.3
Edwards, H.G.4
-
36
-
-
4444331977
-
Development of a simple, noninvasive, clinically relevant model of pressure ulcers in the mouse
-
Stadler I, Zhang RY, Oskoui P, Whittaker MS, Lanzafame RJ (2004) Development of a simple, noninvasive, clinically relevant model of pressure ulcers in the mouse. J Invest Surg 17(4):221-227.
-
(2004)
J Invest Surg
, vol.17
, Issue.4
, pp. 221-227
-
-
Stadler, I.1
Zhang, R.Y.2
Oskoui, P.3
Whittaker, M.S.4
Lanzafame, R.J.5
-
37
-
-
0037372172
-
Abnormal angiogenesis in diabetes mellitus
-
Martin A, Komada MR, Sane DC (2003) Abnormal angiogenesis in diabetes mellitus. Med Res Rev 23(2):117-145.
-
(2003)
Med Res Rev
, vol.23
, Issue.2
, pp. 117-145
-
-
Martin, A.1
Komada, M.R.2
Sane, D.C.3
-
38
-
-
1142297602
-
Role of apoptosis in reperfusion injury
-
Eefting F, et al. (2004) Role of apoptosis in reperfusion injury. Cardiovasc Res 61(3):414-426.
-
(2004)
Cardiovasc Res
, vol.61
, Issue.3
, pp. 414-426
-
-
Eefting, F.1
-
39
-
-
2442538178
-
Understanding chronic wounds: A unifying hypothesis on their pathogenesis and implications for therapy
-
Mustoe T (2004) Understanding chronic wounds: A unifying hypothesis on their pathogenesis and implications for therapy. Am J Surg 187(5A):65S-70S.
-
(2004)
Am J Surg
, vol.187
, Issue.5
, pp. 65S-70S
-
-
Mustoe, T.1
-
40
-
-
84860810441
-
Effect of iron chelation on myocardial infarct size and oxidative stress in ST-elevation-myocardial infarction
-
Chan W, et al. (2012) Effect of iron chelation on myocardial infarct size and oxidative stress in ST-elevation-myocardial infarction. Circ Cardiovasc Interv 5(2):270-278.
-
(2012)
Circ Cardiovasc Interv
, vol.5
, Issue.2
, pp. 270-278
-
-
Chan, W.1
-
41
-
-
53249117183
-
Oxidative stress in normal and impaired wound repair
-
Schäfer M, Werner S (2008) Oxidative stress in normal and impaired wound repair. Pharmacol Res 58(2):165-171.
-
(2008)
Pharmacol Res
, vol.58
, Issue.2
, pp. 165-171
-
-
Schäfer, M.1
Werner, S.2
-
43
-
-
0035989750
-
Becaplermin: Recombinant platelet derived growth factor, a new treatment for healing diabetic foot ulcers
-
Nagai MK, Embil JM (2002) Becaplermin: Recombinant platelet derived growth factor, a new treatment for healing diabetic foot ulcers. Expert Opin Biol Ther 2(2):211-218.
-
(2002)
Expert Opin Biol Ther
, vol.2
, Issue.2
, pp. 211-218
-
-
Nagai, M.K.1
Embil, J.M.2
-
44
-
-
77952815052
-
Benefit-risk assessment of becaplermin in the treatment of diabetic foot ulcers
-
Papanas N, Maltezos E (2010) Benefit-risk assessment of becaplermin in the treatment of diabetic foot ulcers. Drug Saf 33(6):455-461.
-
(2010)
Drug Saf
, vol.33
, Issue.6
, pp. 455-461
-
-
Papanas, N.1
Maltezos, E.2
-
45
-
-
0036729423
-
Offloading diabetic foot wounds using the scotchcast boot: A retrospective study
-
Knowles EA, et al. (2002) Offloading diabetic foot wounds using the scotchcast boot: A retrospective study. Ostomy Wound Manage 48(9):50-53.
-
(2002)
Ostomy Wound Manage
, vol.48
, Issue.9
, pp. 50-53
-
-
Knowles, E.A.1
-
47
-
-
44349147380
-
Dressing-related pain in patients with chronic wounds: An international patient perspective
-
Price PE, et al. (2008) Dressing-related pain in patients with chronic wounds: An international patient perspective. Int Wound J 5(2):159-171.
-
(2008)
Int Wound J
, vol.5
, Issue.2
, pp. 159-171
-
-
Price, P.E.1
-
49
-
-
78349297565
-
Oxidative stress and diabetic complications
-
Giacco F, Brownlee M (2010) Oxidative stress and diabetic complications. Circ Res 107(9):1058-1070.
-
(2010)
Circ Res
, vol.107
, Issue.9
, pp. 1058-1070
-
-
Giacco, F.1
Brownlee, M.2
-
50
-
-
0035856980
-
Biochemistry and molecular cell biology of diabetic complications
-
Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414(6865):813-820.
-
(2001)
Nature
, vol.414
, Issue.6865
, pp. 813-820
-
-
Brownlee, M.1
-
51
-
-
0036249884
-
Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro
-
Prass K, et al. (2002) Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. J Cereb Blood Flow Metab 22(5):520-525.
-
(2002)
J Cereb Blood Flow Metab
, vol.22
, Issue.5
, pp. 520-525
-
-
Prass, K.1
-
52
-
-
57349092150
-
Deferroxamine preconditioning promotes longlasting retinal ischemic tolerance
-
Zhu Y, Zhang L, Gidday JM (2008) Deferroxamine preconditioning promotes longlasting retinal ischemic tolerance. J Ocul Pharmacol Ther 24(6):527-535.
-
(2008)
J Ocul Pharmacol Ther
, vol.24
, Issue.6
, pp. 527-535
-
-
Zhu, Y.1
Zhang, L.2
Gidday, J.M.3
-
53
-
-
0025317328
-
Desferrioxamine as a lipid chain-breaking antioxidant in sickle erythrocyte membranes
-
Hartley A, Davies M, Rice-Evans C (1990) Desferrioxamine as a lipid chain-breaking antioxidant in sickle erythrocyte membranes. FEBS Lett 264(1):145-148.
-
(1990)
FEBS Lett
, vol.264
, Issue.1
, pp. 145-148
-
-
Hartley, A.1
Davies, M.2
Rice-Evans, C.3
-
54
-
-
10344238545
-
Deferoxamine induces prolonged cardiac preconditioning via accumulation of oxygen radicals
-
Dendorfer A, et al. (2005) Deferoxamine induces prolonged cardiac preconditioning via accumulation of oxygen radicals. Free Radic Biol Med 38(1):117-124.
-
(2005)
Free Radic Biol Med
, vol.38
, Issue.1
, pp. 117-124
-
-
Dendorfer, A.1
-
55
-
-
55749108348
-
Transdermal drug delivery
-
Prausnitz MR, Langer R (2008) Transdermal drug delivery. Nat Biotechnol 26(11):1261-1268.
-
(2008)
Nat Biotechnol
, vol.26
, Issue.11
, pp. 1261-1268
-
-
Prausnitz, M.R.1
Langer, R.2
-
56
-
-
33645286192
-
Dermal and transdermal drug delivery systems: Current and future prospects
-
Brown MB, Martin GP, Jones SA, Akomeah FK (2006) Dermal and transdermal drug delivery systems: Current and future prospects. Drug Deliv 13(3):175-187.
-
(2006)
Drug Deliv
, vol.13
, Issue.3
, pp. 175-187
-
-
Brown, M.B.1
Martin, G.P.2
Jones, S.A.3
Akomeah, F.K.4
-
57
-
-
1242308254
-
Current status and future potential of transdermal drug delivery
-
Prausnitz MR, Mitragotri S, Langer R (2004) Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov 3(2):115-124.
-
(2004)
Nat Rev Drug Discov
, vol.3
, Issue.2
, pp. 115-124
-
-
Prausnitz, M.R.1
Mitragotri, S.2
Langer, R.3
-
58
-
-
0033639239
-
Synthesis and solution properties of deferoxamine amides
-
Ihnat PM, Vennerstrom JL, Robinson DH (2000) Synthesis and solution properties of deferoxamine amides. J Pharm Sci 89(12):1525-1536.
-
(2000)
J Pharm Sci
, vol.89
, Issue.12
, pp. 1525-1536
-
-
Ihnat, P.M.1
Vennerstrom, J.L.2
Robinson, D.H.3
-
60
-
-
1542298892
-
Iontophoretic drug delivery
-
Kalia YN, Naik A, Garrison J, Guy RH (2004) Iontophoretic drug delivery. Adv Drug Deliv Rev 56(5):619-658.
-
(2004)
Adv Drug Deliv Rev
, vol.56
, Issue.5
, pp. 619-658
-
-
Kalia, Y.N.1
Naik, A.2
Garrison, J.3
Guy, R.H.4
-
61
-
-
0037190015
-
Phonophoresis: Efficiency, mechanisms and skin tolerance
-
Machet L, Boucaud A (2002) Phonophoresis: Efficiency, mechanisms and skin tolerance. Int J Pharm 243(1-2):1-15.
-
(2002)
Int J Pharm
, vol.243
, Issue.1-2
, pp. 1-15
-
-
Machet, L.1
Boucaud, A.2
-
62
-
-
1542328820
-
Skin electroporation for transdermal and topical delivery
-
Denet AR, Vanbever R, Préat V (2004) Skin electroporation for transdermal and topical delivery. Adv Drug Deliv Rev 56(5):659-674.
-
(2004)
Adv Drug Deliv Rev
, vol.56
, Issue.5
, pp. 659-674
-
-
Denet, A.R.1
Vanbever, R.2
Préat, V.3
-
63
-
-
84891713808
-
Polyvinylpyrrolidone microneedles enable delivery of intact proteins for diagnostic and therapeutic applications
-
Sun W, et al. (2013) Polyvinylpyrrolidone microneedles enable delivery of intact proteins for diagnostic and therapeutic applications. Acta Biomater 9(8):7767-7774.
-
(2013)
Acta Biomater
, vol.9
, Issue.8
, pp. 7767-7774
-
-
Sun, W.1
-
64
-
-
18044394948
-
Transdermal delivery of human growth hormone through RFmicrochannels
-
Levin G, et al. (2005) Transdermal delivery of human growth hormone through RFmicrochannels. Pharm Res 22(4):550-555.
-
(2005)
Pharm Res
, vol.22
, Issue.4
, pp. 550-555
-
-
Levin, G.1
-
65
-
-
4243084415
-
Transdermal microconduits by microscission for drug delivery and sample acquisition
-
Herndon TO, Gonzalez S, Gowrishankar TR, Anderson RR, Weaver JC (2004) Transdermal microconduits by microscission for drug delivery and sample acquisition. BMC Med 2:12.
-
(2004)
BMC Med
, vol.2
, pp. 12
-
-
Herndon, T.O.1
Gonzalez, S.2
Gowrishankar, T.R.3
Anderson, R.R.4
Weaver, J.C.5
-
66
-
-
84857850985
-
Transdermal drug delivery: From micro to nano
-
Pegoraro C, MacNeil S, Battaglia G (2012) Transdermal drug delivery: From micro to nano. Nanoscale 4(6):1881-1894.
-
(2012)
Nanoscale
, vol.4
, Issue.6
, pp. 1881-1894
-
-
Pegoraro, C.1
MacNeil, S.2
Battaglia, G.3
-
67
-
-
84875863346
-
Nanoscale polymeric penetration enhancers in topical drug delivery
-
Yang Y, Bugno J, Hong S (2013) Nanoscale polymeric penetration enhancers in topical drug delivery. Polym Chem.
-
(2013)
Polym Chem
-
-
Yang, Y.1
Bugno, J.2
Hong, S.3
-
68
-
-
78349299793
-
Reverse micelles from amphiphilic branched polymers
-
Jones M-C, Leroux J-C (2010) Reverse micelles from amphiphilic branched polymers. Soft Matter 6(23):5850-5859.
-
(2010)
Soft Matter
, vol.6
, Issue.23
, pp. 5850-5859
-
-
Jones, M.-C.1
Leroux, J.-C.2
-
69
-
-
84864354715
-
Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation
-
Zheng D, et al. (2012) Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation. Proc Natl Acad Sci USA 109(30):11975-11980.
-
(2012)
Proc Natl Acad Sci USA
, vol.109
, Issue.30
, pp. 11975-11980
-
-
Zheng, D.1
-
70
-
-
84886748402
-
Promotion of airway anastomotic microvascular regeneration and alleviation of airway ischemia by deferoxamine nanoparticles
-
Jiang X, et al. (2014) Promotion of airway anastomotic microvascular regeneration and alleviation of airway ischemia by deferoxamine nanoparticles. Biomaterials 35(2):803-813.
-
(2014)
Biomaterials
, vol.35
, Issue.2
, pp. 803-813
-
-
Jiang, X.1
-
71
-
-
84914701269
-
Deferoxamine but not dexrazoxane alleviates liver injury induced by endotoxemia in rats
-
Cermanova J, et al. (2014) Deferoxamine but not dexrazoxane alleviates liver injury induced by endotoxemia in rats. Shock 42(4):372-379.
-
(2014)
Shock
, vol.42
, Issue.4
, pp. 372-379
-
-
Cermanova, J.1
|